Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects
Phase 1
Completed
- Conditions
- N/A submitted trial is conducted on healthy subjects
- Registration Number
- 2023-506633-30-00
- Lead Sponsor
- Pikralida Sp. z o.o.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ended
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Quinta-Analytica s.r.o.
🇨🇿Prague, Czechia
Quinta-Analytica s.r.o.🇨🇿Prague, CzechiaJiří GrimSite contact420777847674jiri.grim@quinta.cz